AU2003240810A1 - Methods, compositions, and growth and differentiation factors for insulin-producing cells - Google Patents
Methods, compositions, and growth and differentiation factors for insulin-producing cells Download PDFInfo
- Publication number
- AU2003240810A1 AU2003240810A1 AU2003240810A AU2003240810A AU2003240810A1 AU 2003240810 A1 AU2003240810 A1 AU 2003240810A1 AU 2003240810 A AU2003240810 A AU 2003240810A AU 2003240810 A AU2003240810 A AU 2003240810A AU 2003240810 A1 AU2003240810 A1 AU 2003240810A1
- Authority
- AU
- Australia
- Prior art keywords
- culture medium
- factors
- cells
- column
- medium contains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/148—Transforming growth factor alpha [TGF-a]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/315—Prolactin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/335—Glucagon; Glucagon-like peptide [GLP]; Exendin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/34—Calcitonin; Calcitonin-gene related peptide [CGRO]; Amylin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/345—Gastrin; Cholecystokinins [CCK]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/35—Vasoactive intestinal peptide [VIP]; Pituitary adenylate cyclase activating polypeptide [PACAP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/37—Parathyroid hormone [PTH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/80—Neurotransmitters; Neurohormones
- C12N2501/83—Tachykinins, e.g. substance P
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/85—Hormones derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/22—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from pancreatic cells
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38400002P | 2002-05-28 | 2002-05-28 | |
US60/384,000 | 2002-05-28 | ||
US44373303A | 2003-05-22 | 2003-05-22 | |
US10/443,733 | 2003-05-22 | ||
PCT/US2003/016734 WO2003100026A2 (fr) | 2002-05-28 | 2003-05-28 | Procedes, compositions et facteurs de croissance et de differenciation pour cellules productrices d'insuline |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003240810A1 true AU2003240810A1 (en) | 2003-12-12 |
Family
ID=29587057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003240810A Abandoned AU2003240810A1 (en) | 2002-05-28 | 2003-05-28 | Methods, compositions, and growth and differentiation factors for insulin-producing cells |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1507552A2 (fr) |
JP (1) | JP2006506047A (fr) |
CN (1) | CN1668324A (fr) |
AU (1) | AU2003240810A1 (fr) |
BR (1) | BR0311362A (fr) |
CA (1) | CA2487858A1 (fr) |
WO (1) | WO2003100026A2 (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2457999T (pt) * | 2002-12-16 | 2019-01-28 | Technion Res & Dev Foundation | Sistema de cultura para células estaminais pluripotentes |
US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
US20050266554A1 (en) | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
US7541185B2 (en) | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
US7625753B2 (en) | 2003-12-23 | 2009-12-01 | Cythera, Inc. | Expansion of definitive endoderm cells |
US7985585B2 (en) | 2004-07-09 | 2011-07-26 | Viacyte, Inc. | Preprimitive streak and mesendoderm cells |
US8586357B2 (en) | 2003-12-23 | 2013-11-19 | Viacyte, Inc. | Markers of definitive endoderm |
WO2005063971A2 (fr) | 2003-12-23 | 2005-07-14 | Cythera, Inc | Endoderme definitif |
EP2377922B1 (fr) * | 2004-04-27 | 2020-04-08 | Viacyte, Inc. | Endoderme exprimant PDX1 |
WO2006001471A1 (fr) * | 2004-06-29 | 2006-01-05 | The University Of Tokyo | Composition medicale favorisant la secretion d'insuline en reponse au glucose |
JP5687816B2 (ja) * | 2004-07-09 | 2015-03-25 | ヴィアサイト,インコーポレイテッド | 胚体内胚葉を分化させるための因子を同定する方法 |
MX2007001772A (es) | 2004-08-13 | 2007-07-11 | Univ Georgia Res Found | Composiciones y metodos para auto-renovacion y diferenciacion de celulas troncales embrionicas humanas. |
WO2006054305A2 (fr) * | 2004-11-22 | 2006-05-26 | Ramot At Tel Aviv University Ltd. | Populations de cellules beta adultes d'ilot de langerhans etendues et redifferenciees permettant de produire de l'insuline et procede d'obtention associe |
AU2006210955A1 (en) * | 2005-01-31 | 2006-08-10 | Es Cell International Pte Ltd. | Directed differentiation of embryonic stem cells and uses thereof |
WO2006108651A2 (fr) * | 2005-04-12 | 2006-10-19 | Develogen Aktiengesellschaft | Utilisation de produits de l'activine pour prevenir et/ou traiter le diabete et/ou le syndrome metabolique |
JP4534039B2 (ja) * | 2005-04-12 | 2010-09-01 | 国立大学法人群馬大学 | 糖代謝促進剤並びに肥満及び糖尿病治療薬のスクリーニング方法 |
JP5584875B2 (ja) * | 2005-04-13 | 2014-09-10 | 国立大学法人 千葉大学 | 成体膵由来膵幹細胞の製造方法 |
EP1957636B1 (fr) | 2005-10-27 | 2018-07-04 | Viacyte, Inc. | Endoderme d'intestin anterieur dorsal et ventral exprimant pdx1 |
US11254916B2 (en) | 2006-03-02 | 2022-02-22 | Viacyte, Inc. | Methods of making and using PDX1-positive pancreatic endoderm cells |
US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
JP6110048B2 (ja) | 2006-03-02 | 2017-04-05 | ヴィアサイト,インコーポレイテッド | 内分泌前駆細胞、膵臓ホルモン発現細胞及びそれらの製造方法 |
CN101501185A (zh) * | 2006-06-09 | 2009-08-05 | 人类起源公司 | 胎盘巢(placental niche)及其培养干细胞的用途 |
US7695963B2 (en) | 2007-09-24 | 2010-04-13 | Cythera, Inc. | Methods for increasing definitive endoderm production |
CA2743641C (fr) | 2008-11-14 | 2024-03-26 | Viacyte, Inc. | Encapsulation de cellules pancreatiques derivees de cellules souches pluripotentes humaines |
US9328331B2 (en) * | 2009-05-21 | 2016-05-03 | Joslin Diabetes Center, Inc. | Compositions and methods for promoting beta cell maturity |
EP2281874A1 (fr) * | 2009-07-31 | 2011-02-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Production de cellules ß |
WO2011071085A1 (fr) * | 2009-12-08 | 2011-06-16 | 国立大学法人東京大学 | Procédé pour produire des cellules induites pour être différenciées à partir de cellules souches pluripotentes |
CA2785966C (fr) | 2009-12-29 | 2020-10-27 | Takeda Pharmaceutical Company Limited | Procede pour la fabrication de cellules de production d'hormones pancreatiques |
EP2546334A4 (fr) * | 2010-03-12 | 2014-10-29 | Fundación Progreso Y Salud | Procédé pour la prolifération "in vitro" de cellules issues de tissus d'origine endodermique |
EP2569430B1 (fr) | 2010-05-12 | 2018-10-17 | The Trustees of Columbia University in the City of New York | Procédés de production de cellules entéroendocrines capables de fabriquer et de sécréter de l'insuline |
US9404087B2 (en) | 2010-12-15 | 2016-08-02 | Kadimastem Ltd. | Insulin producing cells derived from pluripotent stem cells |
EP2683812A4 (fr) * | 2011-03-07 | 2014-12-03 | Massachusetts Inst Technology | Procédés pour transfecter des cellules avec des acides nucléiques |
CA2915091A1 (fr) | 2013-06-11 | 2014-12-18 | President And Fellows Of Harvard College | Cellules ? derivees de cellules souches et compositions et procedes pour generer ces cellules |
EP2840132B1 (fr) * | 2013-08-22 | 2016-11-30 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin | Procédé pour produire par génie génétique des muscles cardiaques (EHM) |
US9404086B2 (en) * | 2014-03-26 | 2016-08-02 | Ge Healthcare Uk Limited | Method for cell differentiation |
US10487314B2 (en) | 2014-06-26 | 2019-11-26 | The Trustees Of Columbia University In The City Of New York | Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells |
WO2016100909A1 (fr) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Procédés de génération de cellules β dérivées de cellules souches et leurs utilisations |
CN107614678B (zh) | 2014-12-18 | 2021-04-30 | 哈佛学院校长同事会 | 干细胞来源的β细胞的产生方法及其使用方法 |
WO2016100898A1 (fr) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Protocole de différentiation dirigée in vitro sans sérum pour générer des cellules b dérivées de cellules souches et leurs utilisations |
IT201700066486A1 (it) * | 2017-06-15 | 2018-12-15 | Azienda Ospedaliero Univ Policlinico S Orsola Malpighi Bologn A | Siero sanguigno per uso nel trattamento di patologie neurodegenerative oftalmologiche |
WO2019017492A1 (fr) * | 2017-07-20 | 2019-01-24 | 国立研究開発法人理化学研究所 | Procédé de maturation de tissu rétinien contenant un épithélium continu |
WO2019099725A1 (fr) | 2017-11-15 | 2019-05-23 | Semma Therapeutics, Inc. | Compositions pour la fabrication de cellules d'ilôts et procédés d'utilisation |
WO2019142833A1 (fr) * | 2018-01-16 | 2019-07-25 | 学校法人慶應義塾 | PROCÉDÉ DE DÉRIVATION DE CELLULES DE REMPLACEMENT DE L'ENDOTHÉLIUM CORNÉEN À PARTIR DE CELLULES iPS |
AU2019320072A1 (en) | 2018-08-10 | 2021-02-25 | Vertex Pharmaceuticals Incorporated | Stem cell derived islet differentiation |
TWI776368B (zh) * | 2020-05-29 | 2022-09-01 | 國璽幹細胞應用技術股份有限公司 | 細胞分化培養基組合物、高分泌量胰島素產生細胞及其製備方法 |
CN115433684A (zh) * | 2022-10-20 | 2022-12-06 | 云南师范大学 | 一种盘基网柄菌细胞同步化方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935852A (en) * | 1997-07-03 | 1999-08-10 | Genetics Institute, Inc. | DNA molecules encoding mammalian cerberus-like proteins |
-
2003
- 2003-05-28 CA CA002487858A patent/CA2487858A1/fr not_active Abandoned
- 2003-05-28 CN CNA03817331XA patent/CN1668324A/zh active Pending
- 2003-05-28 BR BRPI0311362-0A patent/BR0311362A/pt not_active IP Right Cessation
- 2003-05-28 EP EP03731406A patent/EP1507552A2/fr not_active Withdrawn
- 2003-05-28 AU AU2003240810A patent/AU2003240810A1/en not_active Abandoned
- 2003-05-28 WO PCT/US2003/016734 patent/WO2003100026A2/fr active Search and Examination
- 2003-05-28 JP JP2004508268A patent/JP2006506047A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1507552A2 (fr) | 2005-02-23 |
JP2006506047A (ja) | 2006-02-23 |
BR0311362A (pt) | 2006-10-31 |
WO2003100026A2 (fr) | 2003-12-04 |
CA2487858A1 (fr) | 2003-12-04 |
CN1668324A (zh) | 2005-09-14 |
WO2003100026A3 (fr) | 2004-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040259244A1 (en) | Methods, compositions, and growth and differentiation factors for insulin-producing cells | |
AU2003240810A1 (en) | Methods, compositions, and growth and differentiation factors for insulin-producing cells | |
CN100425694C (zh) | 诱导胚胎干细胞向胰腺细胞分化的方法 | |
CN1602351B (zh) | 源自人胚胎干细胞的胰岛细胞 | |
Ilieva et al. | Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas | |
Rosenberg | In vivo cell transformation: neogenesis of beta cells from pancreatic ductal cells | |
Vasavada et al. | Growth factors and beta cell replication | |
US20040121460A1 (en) | Differentiation of stem cells to pancreatic endocrine cells | |
Talavera-Adame et al. | Endothelial cells in co-culture enhance embryonic stem cell differentiation to pancreatic progenitors and insulin-producing cells through BMP signaling | |
US8039254B2 (en) | Populations of expanded and re-differentiated adult islet beta cells capable of producing insulin and methods of generating same | |
WO2004073633A2 (fr) | Methodes et compositions permettant de moduler le developpement de cellules souches | |
EP1567639A2 (fr) | Culture d'ilots pancreatiques humains et leurs utilisations | |
Fantuzzi et al. | In depth functional characterization of human induced pluripotent stem cell-derived beta cells in vitro and in vivo | |
JP2010099069A (ja) | ヒト成体幹細胞のインスリン分泌細胞への分化誘導方法 | |
US20050037490A1 (en) | Medium for preparing dedifferentiated cells | |
Bose et al. | Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation | |
WO2006136374A2 (fr) | Utilisation du gip et/ou de la vitamine d3 et d'analogues correspondants pour ameliorer la differenciation de cellules souches ou progenitrices en cellules productrices d'insuline | |
RU2430158C1 (ru) | Способ дифференцировки стволовых клеток взрослого человека в клетки, секретирующие инсулин | |
Tsaniras | Generating mature β-cells from embryonic stem cells: strategies for late-stage differentiation | |
CN113637630B (zh) | 一种胰岛样细胞团及其制法和应用 | |
Mantovani et al. | Pancreatic Stem Cells and Regenerative Medicine of Endocrine Pancreas | |
KR100354931B1 (ko) | 췌도의 대량 배양증식 및 증식한 췌도에 의한 당뇨치료방법 | |
Yew | GLP-1 and Autocrine TGF-[beta]/BMP SMAD Synergy in Step-wise Initiation and Maturation During [beta]-cell Differentiation of AR42J Cells | |
Shao | PS 022 Beta cells from stem cells | |
Tadros | Induction of human pancreatic mesenchymal stem cells to insulin producing cells for the treatment of type 1 diabetes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK3 | Application lapsed section 142(2)(c) - examination deferred under section 46 no request for examination |